Encellin, Inc.

Palo Alto, CA · Founded 2015 · Biotech · Private

Therapeutic treatments for endocrine disorders using cellular or molecular engineering

Claim this profile

Follows are private to you and power your alerts

Updated · encellin.com

Sector
Biotech
Headquarters
Palo Alto, CA
Founded
2015
Latest Form D
$9.9M, Dec 2023
Total capital
$12M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$12M
2 Form D · last Dec 2023
34 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
14 pending

Capital timeline

20192020202120222023FEDERAL ↑EQUITY ↓Cumulative $12M1st Form D$2.1M2nd Form D$9.9M
20192020202120222023FEDERAL ↑EQUITY ↓Cumulative $12M1st Form D$2.1M2nd Form D$9.9M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$9.9M
  • Private capital raisedForm D · SEC · 1st filing$2.1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Crystal NyitrayExecutive Officer, Director, PromoterNamed in SEC Form D filings
  • Grace WeiExecutive Officer, Director, PromoterNamed in SEC Form D filings
  • Maria del Consuelo ValverdeDirectorNamed in SEC Form D filings
  • Ronald MartellExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 14
  • PendingMethods And Devices For Pre-vascularization Of Implantation Sites And/or Cell Encapsulation DevicesUSPTOApplication 18735879
  • PendingCell Encapulation Devices And Methods Of Using SameUSPTOApplication 18753578
  • PendingCell Encapsulation Devices And Methods Of Using SameUSPTOApplication 18023578
Show all 14 patent records
  • Methods And Devices For Pre-vascularization Of Implantation Sites And/or Cell Encapsulation DevicesMay 8, 2025 · Application 18735879Pending
  • Cell Encapulation Devices And Methods Of Using SameDec 26, 2024 · Application 18753578Pending
  • Cell Encapsulation Devices And Methods Of Using SameOct 5, 2023 · Application 18023578Pending
  • Respirator Face Masks For Protection From Airborne ParticlesApr 27, 2023 · Application 17914004Pending
  • Cell Encapsulation Devices And Methods Of Using SameJun 2, 2022 · Application 17437998Pending
  • Respirator Face Masks For Protection From Airborne ParticlesApplication PCTUS2021024131Pending
  • Cell Encapsulation Devices And Methods Of Using SameApplication 63079127Pending
  • Respirator Face Masks For Protection From Airborne ParticlesApplication 63000081Pending
  • Cell Encapsulation Devices And Methods Of Using SameApplication PCTUS2020022063Pending
  • Cell Encapsulation Devices And Methods Of Using SameApplication 62816675Pending
  • Methods And Devices For Pre-vascularization Of Implantation Sites And/or Cell Encapsulation DevicesApplication PCTUS2022052413Pending
  • Methods And Devices For Pre-vascularization Of Implantation Sites And/or Cell Encapsulation DevicesApplication 63423925Pending
  • Methods And Devices For Pre-vascularization Of Implantation Sites And/or Cell Encapsulation DevicesApplication 63287826Pending
  • Cell Encapsulation Devices And Methods Of Using SameApplication PCTUS2021050705Pending
  • Octagon Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
  • nferenceSimilar federal contract value in Biotech · null in contracts
  • HDL THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
  • MACROGENICS INCSimilar federal contract value in Biotech · null in contracts
  • Akebia Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
  • Silo Pharma, Inc.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .